Newsroom | 23332 results
Sorted by: Latest
-
TeamBest Global Open Letter to the Board of Directors and AROI President: Advancing Cost-Effective Cancer and Vascular Disease Care in India and Worldwide
WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran and his TeamBest Global family of companies—recognized innovators in cost-effective technologies for the diagnosis/treatment of cancer and vascular diseases, including theranostics—have issued an open call for deeper collaboration with the Association of Radiation Oncologists of India (AROI). Suthanthiran founded the International Society of Therapeutic Radiology and Oncology (ISTRO) under the Best Cure Foundation (BCF) and the Brachytherap...
-
Mosaic Clinical Technologies™ Appoints Mike Peresie as President to Accelerate Next-Generation Clinical Workflow Innovation
NASHVILLE, Tenn.--(BUSINESS WIRE)--Mosaic Clinical Technologies™ (Mosaic), the technology and AI services division of Radiology Partners (RP), today announced the appointment of Mike Peresie as President of Mosaic. Mike joins Mosaic as a seasoned digital health executive with more than two decades of experience leading high-growth innovation portfolios and scaled software, network and data businesses. He brings deep expertise in building technology platforms that improve access, quality and aff...
-
Crux Emerges from Stealth with $6.5 Million in Funding, Launches First-Ever No-Cost Benefit to Make Popular Quality-of-Life Medications More Affordable
MCLEAN, Va.--(BUSINESS WIRE)--Crux, the first benefits platform partnering with big pharma and employers of all sizes to expand transparent and affordable access to transformative quality-of-life (QoL) medications, today announced its public launch with $6.5 million in pre-seed funding from Red Cell Partners, a venture studio that builds rapidly scalable, technology-led companies that are bringing revolutionary advancements to market in critical industries like healthcare. U.S.-based employers...
-
a2z Radiology AI Introduces First Multi-Condition Triage for Abdomen-Pelvis CT
BOSTON--(BUSINESS WIRE)--a2z Radiology AI has received U.S. FDA clearance for a2z-Unified-Triage, a single device that flags and prioritizes seven urgent findings on abdomen-pelvis CT scans simultaneously. With RSNA 2025, radiology's largest annual conference, just days away, a2z is positioning itself as a leader in abdomen-pelvis AI. The company is bringing a first-of-its-kind capability to the U.S. market: a single system that triages seven urgent conditions on abdomen-pelvis CTs in one pass....
-
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application...
-
Galux Achieves Breakthrough by Delivering High-Affinity De Novo Antibodies from Only 50 AI Designs, Marking a New Era in Precision Protein Design
SEOUL, South Korea--(BUSINESS WIRE)--GaluxDesign can design high-affinity antibodies from 50 sequences, proving a shift in therapeutic antibodies discovery....
-
GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep learning, Pristina Recon DL sets a new standard in image definition and sharpness. Breast cancer remains one of the most common cancers among women, with one in eight expected to face a diagnosis in their lifetime2 and an estimated 1.1 million breast cancer–related deaths project...
-
DocGo Announces Participation at Upcoming December Investor Conferences
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in December: Noble Capital Markets Emerging Growth Conference (December 3rd) Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings and deliver a presentation on Wednesday, December 3rd at 1:00 PM ET. A webcast of the event will be av...
-
Align Technology Recognized for the 3rd Time in Extel’s 2025 All-America Executive Team Rankings, Including the Most Honored Company Distinction
TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced top-tier recognition in the 2025 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates...
-
Resumen: El tribunal determina que la tecnología HCR™ RNA-ISH de Molecular Instruments no infringe dos patentes de Advanced Cell Diagnostics.
LOS ÁNGELES--(BUSINESS WIRE)--Molecular Instruments, Inc. anunció hoy que el Tribunal Unificado de Patentes (UPC) de la Unión Europea ha determinado que la tecnología HCR™ RNA-ISH de Molecular Instruments no infringe dos patentes registradas por Advanced Cell Diagnostics, Inc. (una empresa del grupo Bio-Techne). En una demanda interpuesta en 2024 ante el Tribunal Unificado de Patentes (expediente n.º UPC CFI 187/2024), Advanced Cell Diagnostics alegaba que la tecnología HCR™ RNA-ISH de Molecula...
